Do all the patients with gastric parietal cell antibodies have pernicious anemia?

A Sun1, Y P Wang, H P Lin

  • 1School of Dentistry, National Taiwan University, Taipei, Taiwan.

Oral Diseases
|September 11, 2012
PubMed

Insights

Only a small fraction of patients with gastric parietal cell antibodies have pernicious anemia. Further investigation is needed to understand the implications of these antibodies in individuals without pernicious anemia.

Area of Science:

  • Gastroenterology
  • Hematology
  • Immunology

Background:

  • Serum gastric parietal cell antibodies (GPCA) are associated with autoimmune conditions.
  • Pernicious anemia (PA) is a condition characterized by vitamin B12 deficiency due to autoimmune gastritis.
  • The relationship between GPCA positivity and the prevalence of PA requires further clarification.

Purpose of the Study:

  • To determine the proportion of GPCA-positive patients who meet the diagnostic criteria for pernicious anemia.
  • To investigate the prevalence of hematological abnormalities in GPCA-positive individuals.

Main Methods:

  • Blood samples from 124 GPCA-positive patients and 124 healthy controls were analyzed.
  • Measurements included hemoglobin (Hb), iron, vitamin B12 levels, and mean corpuscular volume (MCV).
  • Pernicious anemia was defined using WHO criteria: low Hb, high MCV, and low vitamin B12.

Main Results:

  • GPCA-positive patients showed significantly higher rates of Hb, iron, and vitamin B12 deficiencies compared to controls (P < 0.001).
  • A notable percentage of GPCA-positive patients exhibited high MCV (≥ 100 fl).
  • Only 12.9% of GPCA-positive patients were diagnosed with pernicious anemia based on WHO criteria.

Conclusions:

  • The presence of GPCA alone is not sufficient for diagnosing pernicious anemia.
  • A significant number of GPCA-positive individuals have hematological abnormalities without meeting the full criteria for PA.
  • Further research is warranted to understand the clinical significance of GPCA in the absence of overt PA.
Abstract

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastritis-I: Introduction and Types01:27

Gastritis-I: Introduction and Types

Gastritis, defined by the inflammation or irritation of the stomach lining or gastric mucosa, manifests in several distinct forms: acute, chronic, reactive, and a specific subtype known as autoimmune metaplastic atrophic gastritis.
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...